Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Agitation in Alzheimer's Disease
NCT00000179Phase 3Completed
- Sponsor
- National Institute on Aging
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3, randomised, double-blind trial of trazodone and haloperidol in Alzheimer's disease (AD) (4 arms), sponsored by National Institute on Aging. Primary endpoint: Alzheimer's Disease Cooperative Study Clinical Global Impression of Change at 16 weeks. Status: completed.
02
Drugs
trazodonehaloperidol
03
Conditions
Alzheimer's disease (AD)
Beyond the preview
Go deeper on NCT00000179.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00000179.